Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68

Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68

<p>Abstract</p> <p>Background</p> <p>Oncolytic viral therapy represents an alternative therapeutic strategy for the treatment of cancer. We previously described GLV-1h68, a modified Vaccinia Virus with exclusive tropism for tumor cells, and we observed a cell line-speci...

Full description

Bibliographic Details
Main Authors: Bedognetti Davide, Di Pasquale Giovanni, Roychoudhuri Rahul, Pos Zoltan, Chen Nanhai G, Adams Sharon, Reinboth Jennifer, Yu Zhiya, Worschech Andrea, Ascierto Maria, Uccellini Lorenzo, Rossano Fabio, Ascierto Paolo A, Stroncek David F, Restifo Nicholas P, Wang Ena, Szalay Aladar A, Marincola Francesco M
Format: Article
Language:English
Published: BMC 2011-10-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/11/451

Internet

http://www.biomedcentral.com/1471-2407/11/451

Similar Items